Total Payments
$35,170
2023 Payments
$8,110
Companies
5
Transactions
39
Payment Breakdown by Category
Consulting$20,495 (58.3%)
Travel$9,988 (28.4%)
Other$3,500 (10.0%)
Food & Beverage$1,187 (3.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $20,495 | 10 | 58.3% |
| Travel and Lodging | $9,988 | 16 | 28.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,500 | 1 | 10.0% |
| Food and Beverage | $1,187 | 12 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $29,669 | 27 | $0 (2023) |
| Becton, Dickinson and Company | $3,619 | 5 | $0 (2021) |
| PFIZER INC. | $1,691 | 5 | $0 (2018) |
| Hologic, LLC | $101.03 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $90.31 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $8,110 | 7 | Merck Sharp & Dohme LLC ($8,110) |
| 2022 | $3,465 | 2 | Merck Sharp & Dohme LLC ($3,465) |
| 2021 | $5,570 | 3 | Merck Sharp & Dohme Corporation ($3,750) |
| 2020 | $2,275 | 3 | Merck Sharp & Dohme Corporation ($2,275) |
| 2019 | $2,475 | 1 | Merck Sharp & Dohme Corporation ($2,475) |
| 2018 | $13,184 | 22 | Merck Sharp & Dohme Corporation ($9,593) |
| 2017 | $90.31 | 1 | AstraZeneca Pharmaceuticals LP ($90.31) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/26/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $6,710.00 | General |
| 07/26/2023 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 07/14/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $835.91 | General |
| Category: ONCOLOGY | ||||||
| 07/14/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $64.99 | General |
| Category: ONCOLOGY | ||||||
| 07/14/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $59.50 | General |
| Category: ONCOLOGY | ||||||
| 07/14/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $42.27 | General |
| Category: ONCOLOGY | ||||||
| 07/13/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $247.47 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,830.00 | General |
| 04/18/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,635.00 | General |
| 09/20/2021 | Becton, Dickinson and Company | BD Onclarity (Device) | Consulting Fee | Cash or cash equivalent | $1,820.00 | General |
| Category: Women's Health and Cancer | ||||||
| 04/26/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 03/29/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| 11/02/2020 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 05/20/2020 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 02/03/2020 | Merck Sharp & Dohme Corporation | GARDASIL 9 (Biological) | Consulting Fee | Cash or cash equivalent | $275.00 | General |
| Category: VACCINE | ||||||
| 01/02/2019 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $2,475.00 | General |
| 11/20/2018 | PFIZER INC. | BAVENCIO (Drug) | Travel and Lodging | In-kind items and services | $53.56 | General |
| Category: ONCOLOGY | ||||||
| 10/05/2018 | PFIZER INC. | BAVENCIO (Drug) | Travel and Lodging | In-kind items and services | $731.60 | General |
| Category: ONCOLOGY | ||||||
| 10/05/2018 | PFIZER INC. | BAVENCIO (Drug) | Food and Beverage | In-kind items and services | $373.17 | General |
| Category: ONCOLOGY | ||||||
| 10/05/2018 | PFIZER INC. | BAVENCIO (Drug) | Travel and Lodging | In-kind items and services | $287.61 | General |
| Category: ONCOLOGY | ||||||
| 10/05/2018 | PFIZER INC. | BAVENCIO (Drug) | Travel and Lodging | In-kind items and services | $245.37 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2018 | Merck Sharp & Dohme Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| 08/14/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 07/19/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $40.70 | General |
| 07/19/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $23.26 | General |
About Dr. Mark Einstein, MD
Dr. Mark Einstein, MD is a Gynecology healthcare provider based in Newark, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356421812.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Einstein, MD has received a total of $35,170 in payments from pharmaceutical and medical device companies, with $8,110 received in 2023. These payments were reported across 39 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($20,495).
Ad
Practice Information
- Specialty Gynecology
- Other Specialties Obstetrics, Gynecologic Oncology
- Location Newark, NJ
- Active Since 10/17/2006
- Last Updated 01/26/2022
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1356421812
Products in Payments
- BD Onclarity (Device) $3,619
- BAVENCIO (Drug) $1,691
- KEYTRUDA (Biological) $1,250
- GARDASIL 9 (Biological) $275.00
- Fetal Fibronectin (Device) $101.03
- LYNPARZA (Drug) $90.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecology Doctors in Newark
Kathryn Denny, Md, MD
Gynecology — Payments: $92.34
Gynecology $92.34
Dr. Maureen Yablonski, M.d, M.D
Gynecology
Gynecology
Mr. Claude Macajoux, Md, MD
Gynecology
Gynecology
Dr. Theodore Barrett, Md, Facog, MD, FACOG
Gynecology
Gynecology
Ronaldo Domingo, Md, MD
Gynecology
Gynecology
Reshma Parikh, Md, MD
Gynecology
Gynecology